Pauline Kim

Pauline Kim

Auto-generated profile, based on publicly available information

Pauline Kim

Winship Cancer Institute Emory University Atlanta Georgia USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2024 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
SHSanghoon Han
Sanghoon Han
Ramireddy BommireddyRamireddy Bommireddy
Ramireddy Bommireddy
PKPauline Kim
Pauline Kim
PSPeriasamy Selvaraj
Periasamy Selvaraj
DSDong M. Shin
Dong M. Shin
Head and neck squamous cell carcinoma (HNSCC) is a spectrum of heterogeneous malignancies. A variety of genetic, environmental, and lifestyle factors contribute to the development of HNSCC. Carcinogenesis is a multistep process in which cell proliferation–associated oncogenes and cell-cycle regulation–associated tumor suppressor genes are dysregulated, resulting in premalignant lesions. Immune evasion is a critical step in the progression of benign lesions to advanced cancer. This review discusses the advances that have been made in chemoprevention strategies for HNSCC. The rationale for the use of chemopreventive agents to inhibit head and neck cancer development is highlighted by the positive outcomes of several clinical trials. We discuss the potential of some of the commonly studied agents including vitamin A analogs, EGFR inhibitors, COX-2 inhibitors, metabolic modulators, and natural compounds such as green tea, as well as immunotherapy and photodynamic therapy to prevent HNSCC. Our review provides insight into the potential benefits of these agents and the gaps that remain to be addressed. The published results reaffirm the promise of chemoprevention in head and neck cancer and suggest that continued exploration is needed to overcome the limitations. Because the current focus on chemopreventive agents is limited, major efforts in precision oncology approaches and substantial increase in funding will promote research into chemoprevention, which will eventually decrease the incidence of HNSCC.

28 April 2025 in Head & Neck
Verified
Journal Article
Closed access
PKPauline Kim
Pauline Kim
Nabil SabaNabil Saba
Nabil Saba
AMAshley McCook‐Veal
Ashley McCook‐Veal
YLYuan Liu
Yuan Liu
AKAdam M. Klein
Adam M. Klein
DSDong M. Shin
Dong M. Shin